Related Experiment Video
Updated: Feb 12, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Use of oral anticoagulants in patients with atrial fibrillation and renal dysfunction
Tatjana S Potpara1,2, Charles J Ferro3, Gregory Y H Lip1,3,4
1School of Medicine, Belgrade University, Belgrade, Serbia.
Insights
Atrial fibrillation (AF) and chronic kidney disease (CKD) share risk factors and worsen each other. Non-vitamin K antagonist oral anticoagulants (NOACs) are effective for mild-to-moderate CKD, but management for severe CKD remains challenging.
Area of Science:
- Cardiology
- Nephrology
Background:
- Atrial fibrillation (AF) and chronic kidney disease (CKD) are common and interconnected conditions.
- Shared risk factors include older age, hypertension, and diabetes mellitus.
- CKD increases AF risk, while AF can lead to CKD development or progression.
Purpose of the Study:
- To review the efficacy and safety of anticoagulants in patients with AF and CKD.
- To highlight the challenges in managing patients with AF and severe CKD or end-stage renal disease on dialysis.
Main Methods:
- Analysis of data from randomized clinical trials comparing NOACs and warfarin in AF patients with varying degrees of CKD.
- Review of observational cohort studies concerning anticoagulation in advanced CKD.
Main Results:
- NOACs demonstrated similar efficacy and safety to warfarin in AF patients with mild-to-moderate CKD, requiring dose adjustments.
- Evidence for managing AF patients with severe CKD or on dialysis is limited, with conflicting results from observational studies.
- Patients with advanced CKD have increased thromboembolic and bleeding risks.
Conclusions:
- NOACs are a viable option for AF patients with mild-to-moderate CKD when dosed appropriately.
- Management of AF in severe CKD or end-stage renal disease necessitates careful risk-benefit assessment, potentially involving warfarin with close monitoring.
Abstract:
Atrial fibrillation (AF) and chronic kidney disease (CKD) are increasingly prevalent in the general population and share common risk factors such as older age, hypertension and diabetes mellitus. The presence of CKD increases the risk of incident AF, and, likewise, AF increases the risk of CKD development and/or progression. Both conditions are associated with substantial thromboembolic risk, but patients with advanced CKD also exhibit a paradoxical increase in bleeding risk. In the landmark randomized clinical trials that compared non-vitamin K antagonist oral anticoagulants (NOACs) with warfarin for thromboprophylaxis in patients with AF, the efficacy and safety of NOACs in patients with mild-to-moderate CKD were similar to those in patients without CKD. Dose adjustment of NOACs as per the prescribing label is required in this population. Owing to limited trial data, evidence-based recommendations for the management of patients with AF and severe CKD or end-stage renal disease on dialysis are lacking. Observational cohort studies have reported conflicting results, and the management of these particularly vulnerable patients remains challenging and requires careful assessment of stroke and bleeding risk and, where appropriate, use of warfarin with good-quality anticoagulation control.
Related Concept Videos
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid Fibrils
Fibril-associated Collagen
For example, the type II collagen fibrils in cartilage have covalently bound type IX fibril-associated collagens at regular intervals. Other types of fibril-associated collagens are...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Oral Cavity
Teeth: The teeth are the hardest structures in our bodies. Humans have two sets of teeth throughout their lifetime: deciduous (baby) teeth and permanent teeth. Each tooth consists of several parts: the crown (visible part), the root (embedded in the jaw), enamel (hard outer...

